Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Molecules ; 23(6)2018 Jun 07.
Article in English | MEDLINE | ID: mdl-29875344

ABSTRACT

The problem of the correlation of indolic molecules with special regard to melatonin and immune processes has been widely investigated. However, there are only few studies focusing on circadian variation of peripheral blood leukocytes. The purpose of this study is thus to understand the influence of MLT on leukocyte populations and its correlation with leukocyte distribution. This is accomplished by administrating placebo and melatonin to different groups of individuals and by performing a biophysical Gaussian analysis on the number of leukocytes by means of a comparison of their p.m. vs. a.m. variations under the effect of placebo and of melatonin and via a comparison in the morning between leukocytes population of untreated group and MLT group. It is shown that: (a) melatonin has the effect of narrowing the normal distribution concentrating most of the individuals towards the mean value of the observed variation of leukocytes population and (b) the individuals who have not received either placebo or supplement have a leukocyte population that follows a normal distribution. These results confirm the crucial role played by melatonin, as the most representative of indolic amide in biological systems, in the circadian peripheral variations of leukocyte numbers because counts of white blood cells are essential in medical urgency and differential diagnosis situations. Hence, further studies are suggested to account for these physiological variations and for the evaluation of the full involvement of the action of MLT on leukocytes distribution.


Subject(s)
Amides/metabolism , Data Interpretation, Statistical , Indoles/metabolism , Leukocyte Count , Leukocytes/drug effects , Melatonin/pharmacology , Adult , Biophysical Phenomena , Circadian Rhythm , Diagnosis, Differential , Female , Humans , Male , Melatonin/administration & dosage , Middle Aged , Placebos
2.
Int J Mol Sci ; 17(3): 341, 2016 Mar 07.
Article in English | MEDLINE | ID: mdl-26959015

ABSTRACT

For several years, oncostatic and antiproliferative properties, as well as thoses of cell death induction through 5-methoxy-N-acetiltryptamine or melatonin treatment, have been known. Paradoxically, its remarkable scavenger, cytoprotective and anti-apoptotic characteristics in neurodegeneration models, such as Alzheimer's disease and Parkinson's disease are known too. Analogous results have been confirmed by a large literature to be associated to the use of many other bioactive molecules such as resveratrol, tocopherol derivatives or vitamin E and others. It is interesting to note that the two opposite situations, namely the neoplastic pathology and the neurodegeneration, are characterized by deep alterations of the metabolome, of mitochondrial function and of oxygen consumption, so that the oncostatic and cytoprotective action can find a potential rationalization because of the different metabolic and mitochondrial situations, and in the effect that these molecules exercise on the mitochondrial function. In this review we discuss historical and general aspects of melatonin, relations between cancers and the metabolome and between neurodegeneration and the metabolome, and the possible effects of melatonin and of other bioactive molecules on metabolic and mitochondrial dynamics. Finally, we suggest a common general mechanism as responsible for the oncostatic/cytoprotective effect of melatonin and of other molecules examined.


Subject(s)
Cell Respiration/drug effects , Cytostatic Agents/pharmacology , Melatonin/pharmacology , Mitochondria/drug effects , Animals , Humans , Metabolome/drug effects , Mitochondria/metabolism , Mitochondrial Dynamics/drug effects , Neoplasms/drug therapy , Neoplasms/metabolism , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/prevention & control , Oxygen Consumption/drug effects
3.
Int J Mol Sci ; 15(5): 8893-930, 2014 May 19.
Article in English | MEDLINE | ID: mdl-24857919

ABSTRACT

Over the last 100 years, many studies have been performed to determine the biochemical and histopathological phenomena that mark the origin of neoplasms. At the end of the last century, the leading paradigm, which is currently well rooted, considered the origin of neoplasms to be a set of genetic and/or epigenetic mutations, stochastic and independent in a single cell, or rather, a stochastic monoclonal pattern. However, in the last 20 years, two important areas of research have underlined numerous limitations and incongruities of this pattern, the hypothesis of the so-called cancer stem cell theory and a revaluation of several alterations in metabolic networks that are typical of the neoplastic cell, the so-called Warburg effect. Even if this specific "metabolic sign" has been known for more than 85 years, only in the last few years has it been given more attention; therefore, the so-called Warburg hypothesis has been used in multiple and independent surveys. Based on an accurate analysis of a series of considerations and of biophysical thermodynamic events in the literature, we will demonstrate a homogeneous pattern of the cancer stem cell theory, of the Warburg hypothesis and of the stochastic monoclonal pattern; this pattern could contribute considerably as the first basis of the development of a new uniform theory on the origin of neoplasms. Thus, a new possible epistemological paradigm is represented; this paradigm considers the Warburg effect as a specific "metabolic sign" reflecting the stem origin of the neoplastic cell, where, in this specific metabolic order, an essential reason for the genetic instability that is intrinsic to the neoplastic cell is defined.


Subject(s)
Models, Theoretical , Neoplastic Stem Cells/metabolism , Antineoplastic Agents/therapeutic use , Cellular Microenvironment , Drug Resistance, Neoplasm , Glycolysis , Humans , Metabolic Networks and Pathways , Mitochondria/metabolism , Neoplasms/drug therapy , Neoplasms/metabolism , Neoplasms/pathology , Thermodynamics
4.
Neuro Endocrinol Lett ; 32(3): 292-300, 2011.
Article in English | MEDLINE | ID: mdl-21712781

ABSTRACT

BACKGROUND: Some researches have shown that melatonin (MLT) has effects on the erythrocyte deformability and on the osmotic fragility which, currently, seem to be heterogeneous and fragmentary. OBJECTIVE: This work wished to evaluate in vitro the possible modifying action of MLT at pharmaceutical doses on the osmotic fragility of rat blood samples treated with cytochalasin B (CB). The variation of the lactate dehydrogenase (LDH) levels have been measured because LDH is an enzyme which is considered an important marker of hemolysis. Working in a strongly reducing environment has been necessary in order to avoid possible antioxidant actions of MLT, measuring the plasma levels of malondialdehyde and total phospholipids in order to highlight possible MLT actions which are not related to its recognized antioxidant properties. RESULTS: The data show a possible MLT action which strengthens the CB action on the osmotic fragility and on the membrane deformability of the erythrocytes. CONCLUSIONS: Under the adopted working conditions, a direct relation of MLT with the biochemical dynamics of the cytoskeleton-mediated processes can be suggested. Further studies will be needed to clarify the mechanisms and the extent of the observed phenomena.


Subject(s)
Antioxidants/pharmacology , Cytochalasin B/pharmacology , Erythrocyte Deformability/drug effects , Erythrocytes/drug effects , Melatonin/pharmacology , Osmotic Fragility/drug effects , Actin Cytoskeleton/metabolism , Actins/chemistry , Actins/metabolism , Animals , Antioxidants/metabolism , Biomarkers/analysis , Biomarkers/metabolism , Erythrocyte Membrane/drug effects , Hemolysis/drug effects , L-Lactate Dehydrogenase/metabolism , Malondialdehyde/metabolism , Phospholipids/metabolism , Protein Structure, Secondary , Rats , Rats, Wistar
5.
Neuro Endocrinol Lett ; 30(5): 582-91, 2009.
Article in English | MEDLINE | ID: mdl-20035269

ABSTRACT

BACKGROUND: In the course of the last few years, various studies have researched the relations linking melatonin (MLT) with hematopoiesis and the immune-hematopoietic system. Nevertheless, to date there are numerous issues still opened and many questions are yet unanswered. Much emphasis has been recently placed on the reducing role of MLT, which has been demonstrated by many studies to mitigate the genotoxic damage inflicted by various alkylating agents. Although in vitro MLT has shown to be effective in limiting the cytological alterations provoked by chemotherapeutic drugs, some clinical studies seem to point to a somewhat lower effectiveness in countering chemotherapy-induced leukopenia and anemia. OBJECTIVE: The aim of this study was to evaluate the activity exerted by pharmacological doses of MLT in limiting leukopenia, anemia and other hemocytometric modifications in animals facing acute toxicity caused by the treatment with cyclophosphamide (CP). Moreover, we have compared the activity of MLT with well-known alpha-tocopherol/ascorbic acid antioxidant system. RESULTS: Our results indicate that overall MLT exerts a remarkable countering activity towards leukopenia and anemia in the early phase of administration of CP. CONCLUSIONS: Our findings suggest possible active involvement of MLT in hematopoiesis and erythrocyte- and leukocyte turnover. This paper summarizes the essential aspects of the available literature, researching the possible relations between MLT and immune-hematopoietic system.


Subject(s)
Anemia/drug therapy , Antineoplastic Agents, Alkylating/toxicity , Bone Marrow/drug effects , Cyclophosphamide/toxicity , Leukopenia/drug therapy , Melatonin , Animals , Bone Marrow/metabolism , Humans , Melatonin/pharmacology , Melatonin/therapeutic use , Random Allocation , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...